Document Detail


Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer.
MedLine Citation:
PMID:  16921401     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
G Russo; M La Spina; N Disma; M Astuto
Publication Detail:
Type:  Comment; Letter     Date:  2006-08-21
Journal Detail:
Title:  Bone marrow transplantation     Volume:  38     ISSN:  0268-3369     ISO Abbreviation:  Bone Marrow Transplant.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-04     Completed Date:  2007-01-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8702459     Medline TA:  Bone Marrow Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  575-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Anti-Infective Agents / therapeutic use
Child
Child, Preschool
Female
Humans
Infant
Male
Neoplasms / complications*
Protein C / therapeutic use*
Recombinant Proteins / therapeutic use
Sepsis / drug therapy*,  etiology
Chemical
Reg. No./Substance:
0/Anti-Infective Agents; 0/Protein C; 0/Recombinant Proteins; 0/drotrecogin alfa activated
Comments/Corrections
Comment On:
Bone Marrow Transplant. 2005 Oct;36(8):721-4   [PMID:  16086043 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by pr...
Next Document:  Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular s...